Vicero's VCR-036: A Breakthrough Dual-Targeting VHH Antibody for Cancer Immunotherapy

27·02·2025

IBI Ag Secures $6.1 Million Investment to Accelerate Single-Domain Antibody-Based Bio-Insecticides

24·02·2025

MoonLake Immunotherapeutics Announces Successful Outcome on both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis

14·06·2024

Nanobodies: a promising tool to perturb ApoE4 activity in Alzheimer's disease pathology

04·06·2024

VUB Team Develops Nanobody-Based Technology Against Liver Inflammation

29·02·2024

Laboratory Animals - General Code of Animal Welfare in China

29·02·2024